NaDeNo Selected for EIC Accelerator Funding
Enabling a phase 1 clinical trial of PACAB-002 and [...]
NaDeNo seeks funding ahead of clinical entry
Nordic Life Science Days With a base at AstraZeneca’s [...]
NaDeNo Presents at GoCo Investor Day
Organized by GoCo Health Innovation City and AstraZeneca’s BioVentureHub [...]
NaDeNo joins AstraZeneca BioVentureHub
We are proud to announce that NaDeNo Nanoscience AS has [...]
NaDeNo Welcomes Dr. Jens Bjørheim as Chief Medical Officer
We’re excited to welcome Jens Bjørheim to the NaDeNo team [...]
NaDeNo Tops PHOENIX OITB Rankings: A Big Leap Toward Clinical Trials
We’re thrilled to share that out of many exceptional [...]
NaDeNo welcomes Gudrun Trøite as Head of Operations
We are thrilled to welcome Gudrun Trøite to the NaDeNo [...]
Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models
Read the full publication here What you’ll learn in this [...]
NaDeNo Feaured in Norwegian SciTechNews
What you’ll learn in this article: This article from Norwegian [...]
NaDeNo referenced in Norwegian Scitech News — Combating severe cancer with a new drug delivery system
Reda the full article here Peritoneal cancer is difficult to [...]
